Tandem Diabetes Care Announces First Quarter 2026 Financial Results
Tandem Diabetes Care, Inc. reported its financial results for Q1 2026, achieving record shipments, sales, and gross margin with over 29,000 pumps shipped worldwide, including 19,000 in the U.S. The company reaffirmed its financial guidance for the year ending December 31, 2026.
SAN DIEGO–(BUSINESS WIRE)–Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended March 31, 2026 and reaffirmed financial guidance for the year ending December 31, 2026. First Quarter 2026 Financial and Strategic Highlights Achieved record first quarter pump shipments, sales and gross margin: Shipments of more than 29,000 pumps worldwide, including 19,000 pumps in the United States Sales o